Get the Stockscreener App
20.96
2.51%
-0.5254
Nurix Therapeutics Inc Stock (NRIX) Forecast
The Nurix Therapeutics Inc (NRIX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $31.80, representing a +51.71% increase from the current price of $20.96. The highest analyst price target is $42.22, and the lowest is $21.39.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NRIX Price Target
Average 27.75
(+32.36% Upside)
Is Nurix Therapeutics Inc (NRIX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.08 | Neutral |
| STOCH(9,6) | 22.36 | Neutral |
| STOCHRSI(14) | 7.6129 | Buy |
| MACD(12,26) | -0.9881 | Sell |
| ADX(14) | 24.68 | Neutral |
| William %R | -93.72 | Buy |
| CCI(14) | -46.07 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
21.94
Sell
|
22.17
Sell
|
| MA20 |
24.02
Sell
|
23.10
Sell
|
| MA50 |
23.97
Sell
|
23.67
Sell
|
| MA100 |
23.46
Sell
|
22.66
Sell
|
| MA200 |
19.39
Buy
|
19.55
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, NRIX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NRIX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.08 indicates that NRIX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.36 indicates that NRIX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.6129 indicates that NRIX is oversold. This suggests that NRIX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.68 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -46.07 indicates that NRIX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NRIX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nurix Therapeutics Inc financial reports and earnings history, Nurix Therapeutics Inc (NRIX) stock could reach $25.59 by 2030, $7.0303 by 2040 and $11.60 by 2050. See the projected annual prices until 2050 of the Nurix Therapeutics Inc stock below:
- Nurix Therapeutics Inc (NRIX) is expected to reach an average price of $2.3453 in 2035, with a high prediction of $4.8744 and a low estimate of $3.7053. This indicates an $-88.81% rise from the last recorded price of $20.96.
- Nurix Therapeutics Inc (NRIX) stock is projected to chart a bullish course in 2040, with an average price target of $6.5412, representing an $-68.80% surge from its current level. The forecast ranges from a conservative $7.0842 to a sky-high $7.0303.
- Our analysts predict Nurix Therapeutics Inc (NRIX) to jump -37.27% by 2045, soaring from $13.39 to an average price of $13.15, potentially reaching $13.37. While $13.39 is the low estimate, the potential upside is significant.
- Nurix Therapeutics Inc (NRIX) stock is expected to climb by 2050, reaching an average of $12.56, a $-40.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.60 and $11.27, respectively, highlighting the market's uncertainty.
Nurix Therapeutics Inc Stock (NRIX) Year by Year Forecast
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2025
Nurix Therapeutics Inc Stock (NRIX) is expected to reach an average price of $27.75 in 2025, with a high prediction of $42.22 and a low estimate of $13.28. This indicates an +32.36% rise from the last recorded price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $24.22 | $21.39 | $42.22 | +15.55% |
| February, 2025 | $23.45 | $20.35 | $31.28 | +11.84% |
| March, 2025 | $20.40 | $19.00 | $30.47 | -2.69% |
| April, 2025 | $23.36 | $18.49 | $27.08 | +11.43% |
| May, 2025 | $19.27 | $17.33 | $24.71 | -8.06% |
| June, 2025 | $24.91 | $16.06 | $29.46 | +18.81% |
| July, 2025 | $27.75 | $23.13 | $29.26 | +32.36% |
| August, 2025 | $24.60 | $23.94 | $32.03 | +17.35% |
| September, 2025 | $22.68 | $21.93 | $27.02 | +8.20% |
| October, 2025 | $24.77 | $22.18 | $30.91 | +18.13% |
| November, 2025 | $23.00 | $20.19 | $25.57 | +9.70% |
| December, 2025 | $13.89 | $13.28 | $26.94 | -33.74% |
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2026
The predicted value for Nurix Therapeutics Inc (NRIX) in 2026 is set at an average of $8.7785. Estimates vary from a peak of $15.08 to a trough of $2.4736, indicating an -58.13% surge from the present price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.39 | $11.46 | $15.08 | -40.88% |
| February, 2026 | $8.5763 | $8.3363 | $13.36 | -59.09% |
| March, 2026 | $8.8893 | $7.4028 | $10.07 | -57.60% |
| April, 2026 | $5.9906 | $5.6406 | $10.46 | -71.43% |
| May, 2026 | $3.9736 | $2.4736 | $7.2088 | -81.05% |
| June, 2026 | $6.1066 | $3.8151 | $7.1284 | -70.87% |
| July, 2026 | $11.56 | $6.0032 | $12.90 | -44.87% |
| August, 2026 | $11.79 | $10.17 | $14.97 | -43.76% |
| September, 2026 | $10.97 | $9.8992 | $12.72 | -47.66% |
| October, 2026 | $6.1053 | $6.0653 | $11.92 | -70.88% |
| November, 2026 | $7.8983 | $5.5836 | $8.1683 | -62.33% |
| December, 2026 | $7.5996 | $6.4596 | $10.27 | -63.75% |
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nurix Therapeutics Inc (NRIX) is $4.8443, with a high forecast of $9.3896 and a low forecast of $0.299. This indicates an -76.89% decrease from the last price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.6226 | $5.5326 | $8.3044 | -73.18% |
| February, 2027 | $7.9657 | $4.911 | $8.2157 | -62.00% |
| March, 2027 | $5.037 | $4.877 | $8.7005 | -75.97% |
| April, 2027 | $3.91 | $3.69 | $5.422 | -81.35% |
| May, 2027 | $4.703 | $3.7547 | $4.9965 | -77.57% |
| June, 2027 | $5.7643 | $3.9113 | $9.3896 | -72.50% |
| July, 2027 | $6.3774 | $4.8526 | $6.5526 | -69.58% |
| August, 2027 | $5.4804 | $4.7621 | $7.3039 | -73.86% |
| September, 2027 | $5.2417 | $4.6234 | $7.0869 | -75.00% |
| October, 2027 | $4.0747 | $3.7847 | $5.2099 | -80.56% |
| November, 2027 | $4.4577 | $3.7095 | $5.3866 | -78.74% |
| December, 2027 | $0.419 | $0.299 | $5.211 | -98.00% |
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2028
In 2028, Nurix Therapeutics Inc (NRIX) is projected to reach an average price of $12.89, with a high projection of $25.75 and a low estimate of $0.0356. This indicates an -38.51% fall from the last price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9421 | $0.0356 | $2.3338 | -95.51% |
| February, 2028 | $2.6151 | $0.6403 | $2.6751 | -87.53% |
| March, 2028 | $5.6164 | $2.2934 | $6.5264 | -73.21% |
| April, 2028 | $3.6794 | $3.4294 | $5.9041 | -82.45% |
| May, 2028 | $8.1707 | $3.6177 | $8.4857 | -61.03% |
| June, 2028 | $9.2737 | $8.1137 | $11.95 | -55.76% |
| July, 2028 | $9.4768 | $8.412 | $14.00 | -54.80% |
| August, 2028 | $7.5465 | $4.7865 | $10.63 | -64.00% |
| September, 2028 | $11.93 | $3.3995 | $18.21 | -43.08% |
| October, 2028 | $22.99 | $10.30 | $25.75 | +9.65% |
| November, 2028 | $13.92 | $11.45 | $24.28 | -33.60% |
| December, 2028 | $17.88 | $10.81 | $18.68 | -14.70% |
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2029
The 2029 price forecast for Nurix Therapeutics Inc Stock (NRIX) is $25.76 on average, with a high prediction of $40.92 and a low estimate of $10.59. This represents an +22.85% increase from the previous price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $27.92 | $16.96 | $36.06 | +33.18% |
| February, 2029 | $28.83 | $18.84 | $40.92 | +37.50% |
| March, 2029 | $27.43 | $23.19 | $40.08 | +30.85% |
| April, 2029 | $25.25 | $19.50 | $31.48 | +20.43% |
| May, 2029 | $19.83 | $14.74 | $36.59 | -5.41% |
| June, 2029 | $23.69 | $14.87 | $25.69 | +12.98% |
| July, 2029 | $16.83 | $12.95 | $24.53 | -19.71% |
| August, 2029 | $15.55 | $15.51 | $21.57 | -25.85% |
| September, 2029 | $19.80 | $10.59 | $20.20 | -5.55% |
| October, 2029 | $21.31 | $17.11 | $24.02 | +1.67% |
| November, 2029 | $25.23 | $20.13 | $26.64 | +20.35% |
| December, 2029 | $16.86 | $16.58 | $24.72 | -19.60% |
Nurix Therapeutics Inc Stock (NRIX) Price Forecast for 2030
Nurix Therapeutics Inc Stock (NRIX) is expected to reach an average price of $12.89 in 2030, with a high forecast of $25.59 and a low forecast of $0.1857. This signifies an -38.54% decrease from the last price of $20.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.44 | $16.67 | $25.59 | +11.80% |
| February, 2030 | $16.47 | $16.35 | $23.98 | -21.42% |
| March, 2030 | $18.46 | $14.92 | $21.69 | -11.94% |
| April, 2030 | $7.2369 | $6.2469 | $20.05 | -65.48% |
| May, 2030 | $5.5695 | $4.523 | $9.8265 | -73.43% |
| June, 2030 | $4.3056 | $2.2656 | $6.5125 | -79.46% |
| July, 2030 | $3.5081 | $2.1481 | $5.3566 | -83.27% |
| August, 2030 | $0.5458 | $0.5612 | $3.7946 | -97.40% |
| September, 2030 | $0.5103 | $0.5163 | $0.6046 | -97.57% |
| October, 2030 | $3.3428 | $0.1857 | $3.6328 | -84.05% |
| November, 2030 | $6.0489 | $2.8694 | $7.9194 | -71.15% |
| December, 2030 | $5.585 | $4.9685 | $10.03 | -73.36% |
1.05%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):